STOCK TITAN
  1. Home
  2. Sec-filings
  3. CCAP
  4. [Form 4] Crescent Capital BDC, Inc. Insider Trading Activity

Crescent Capital 10% holder sells 56K shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. (CCAP) reported that Fidelity & Guaranty Life Insurance Company, a ten percent owner, sold a total of 56,285 shares of Common Stock in open-market or private transactions on September 1 and September 2, 2026, under a Rule 10b5-1 trading plan.

The reported sales consisted of 11,285 shares at $10.50 per share on September 1 and 45,000 shares at a volume-weighted average price of about $10.44 per share on September 2, with execution prices ranging from $10.38 to $10.59. Some of the reported holdings are owned by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.

Positive

  • None.

Negative

  • None.
Insider FIDELITY & GUARANTY LIFE INSURANCE CO
Role 10% Owner
Sold 56,285 shs ($589K)
Type Security Shares Price Value
Sale Common Stock F3, F2 45,000 $10.4448 $470K
Sale Common Stock F1, F2 11,285 $10.50 $118K
Holdings After Transaction: Common Stock — 3,961,279 shares (Direct)
Footnotes (3)
  1. F1. The shares were sold in multiple transactions at prices ranging from $10.48 to $10.59 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. F2. Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.
  3. F3. The shares were sold in multiple transactions at prices ranging from $10.38 to $10.51 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares sold September 1, 2026 11,285 shares of Common Stock Open-market or private sale reported for September 1, 2026
Sale price September 1, 2026 $10.50 per share Price for 11,285 Common Stock shares sold on September 1, 2026
Shares sold September 2, 2026 45,000 shares of Common Stock Open-market or private sale reported for September 2, 2026
VWAP price September 2, 2026 $10.4448 per share Volume-weighted average price for 45,000 shares sold on September 2, 2026
Price range September 1, 2026 $10.48–$10.59 per share Range of execution prices for the September 1, 2026 transactions
Price range September 2, 2026 $10.38–$10.51 per share Range of execution prices for the September 2, 2026 transactions
Total shares sold 56,285 shares Aggregate of the two reported sales of CCAP Common Stock
Rule 10b5-1 trading plan regulatory
"transactions were made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
volume weighted average price financial
"The price reported reflects the volume weighted average price"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
ten percent owner regulatory
"identified as a ten percent owner of Crescent Capital BDC"

FAQ

What insider activity did CCAP disclose in this Form 4?
CCAP disclosed that Fidelity & Guaranty Life Insurance Company, a ten percent owner, reported two open-market or private sales of its Common Stock holdings on September 1 and 2, 2026, totaling 56,285 shares.

How many CCAP shares were sold and on which dates?
The reporting person sold a total of 56,285 CCAP Common Stock shares: 11,285 shares on September 1, 2026 and 45,000 shares on September 2, 2026.

At what prices were the CCAP shares sold in this Form 4?
On September 1, 2026, 11,285 shares were sold at $10.50 per share. On September 2, 2026, 45,000 shares were sold at a volume-weighted average price of $10.4448 per share, with trade prices between $10.38 and $10.51–10.59 per share as disclosed.

Were the CCAP insider sales made under a Rule 10b5-1 trading plan?
Yes. The filing affirms that the transactions were made under a Rule 10b5-1 trading plan, which is a pre-arranged trading program intended to permit systematic share sales by the reporting person.

Who is the reporting person in this CCAP Form 4 and what is their status?
The reporting person is Fidelity & Guaranty Life Insurance Company. It is identified in the filing as a ten percent owner of Crescent Capital BDC, Inc., and not as a director or officer of the company.

Were any CCAP shares held through an affiliated entity in this filing?
Yes. A footnote explains that certain reported shares are held by Fidelity & Guaranty Life Insurance Company of New York, which is a wholly owned subsidiary of Fidelity & Guaranty Life Insurance Company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FIDELITY & GUARANTY LIFE INSURANCE CO
(Last)(First)(Middle)
801 GRAND AVENUE, SUITE 2600
(Street)
DES MOINES IOWA 50309
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Crescent Capital BDC, Inc. [ CCAP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026S11,285D$10.5(1)4,006,279(2)D
Common Stock09/02/2026S45,000D$10.4448(3)3,961,279(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares were sold in multiple transactions at prices ranging from $10.48 to $10.59 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2. Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.
3. The shares were sold in multiple transactions at prices ranging from $10.38 to $10.51 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Tessa Cantonwine, Secretary09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR